Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Clinical Trials by G7 Countries: Proportion of Epidermolysis Bullosa to Dermatology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Sponsors 21
Top Companies Participating in Epidermolysis Bullosa Therapeutics Clinical Trials 22
Prominent Drugs 24
Clinical Trial Profile Snapshots 25
Appendix 54
Abbreviations 54
Definitions 54
Research Methodology 55
Secondary Research 55
About GlobalData 56
Contact Us 56
Disclaimer 56
Source 57
List of Tables
Epidermolysis Bullosa Therapeutics, Global, Clinical Trials by Region, 2016* 5
Epidermolysis Bullosa Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Epidermolysis Bullosa Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Epidermolysis Bullosa Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8
Epidermolysis Bullosa Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9
Epidermolysis Bullosa Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
Epidermolysis Bullosa Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11
Proportion of Epidermolysis Bullosa to Dermatology Clinical Trials, G7 Countries (%), 2016* 12
Epidermolysis Bullosa Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Epidermolysis Bullosa Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Epidermolysis Bullosa Therapeutics, Global, Clinical Trials by Phase, 2016* 15
Epidermolysis Bullosa Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 16
Epidermolysis Bullosa Therapeutics, Global, Clinical Trials by Trial Status, 2016* 17
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, by End Point Status, 2016* 18
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 19
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 20
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 21
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 23
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 24
List of Figures
Epidermolysis Bullosa Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Epidermolysis Bullosa Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Epidermolysis Bullosa Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Epidermolysis Bullosa Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8
Epidermolysis Bullosa Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9
Epidermolysis Bullosa Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10
Epidermolysis Bullosa Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 11
Proportion of Epidermolysis Bullosa to Dermatology Clinical Trials, G7 Countries (%), 2016* 12
Epidermolysis Bullosa Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Epidermolysis Bullosa Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Epidermolysis Bullosa Therapeutics, Global, Clinical Trials by Phase (%), 2016* 15
Epidermolysis Bullosa Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 16
Epidermolysis Bullosa Therapeutics, Global, Clinical Trials by Trial Status, 2016* 17
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, by End Point Status, 2016* 18
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 19
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 20
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 21
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 22
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 24
GlobalData Methodology 55